PDS Biotechnology (PDSB) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

PDSB is expected to report earnings to rise 34.04% to -30 cents per share on November 12

PDS Biotechnology PDSB Stock Earnings Reports

Q3'24

Est.

$-0.31

Q2'24

Beat

by $0.10

Q1'24

Beat

by $0.07

Q4'23

Beat

by $0.09

Q3'23

Beat

by $0.10

The last earnings report on August 13 showed earnings per share of -23 cents, beating the estimate of -33 cents. With 452.53K shares outstanding, the current market capitalization sits at 124.08M.

View a ticker or compare two or three

Compare

PDSB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PDSB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PDSB (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

303A College Road

Phone

+1 800 208-3343

Employees

Web

https://www.pdsbiotech.com